Public recall detail

TEVA-Codeine Tablets: out of specification on friability test (broken tablet) during stability testing for affected lots.

2024-12-20

medium
Recall Safety notice
Quick summary

Quick summary: TEVA-Codeine Tablets: out of specification on friability test (broken tablet) during stability testing for affected lots. . Date: 2024-12-20.

Recommended action

Recommended action: compare your product with the official notice and follow the instructions published by the official source.

Recall details

Quick summary: TEVA-Codeine Tablets: out of specification on friability test (broken tablet) during stability testing for affected lots. . Date: 2024-12-20.

Official details

Affected product details

Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.

BrandTeva Canada Limited, Brand, TEVA-Codeine Tablets
ProductTEVA-Codeine Tablets
IssueHealth products - Product safety
Recall classType II
IdentificationRA-76728

Affected products

BrandBrand
ProductProduct
DIN / NPN / authorizationMarket Authorization
Dosage formDosage Form
Strength`Strength
LotLot
BrandTEVA-Codeine Tablets
ProductTEVA-Codeine Tablets
DIN / NPN / authorizationDIN 00593451
Dosage formTablet
StrengthCodeine Phosphate 30mg
Lot688579, 689203, 688771, 689154, 690234, 691161, 691891

Issue

This recall is due to an out of specification on friability test (broken tablet) during stability testing for affected lots.

What you should do

  • Verify if your product is affected.
  • Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
  • Contact the recalling firm if you have any questions about the recall.
  • Report any health product related side effects to Health Canada.
  • Report any other health product safety complaints to Health Canada.
Additional official information
AudienceGeneral public Healthcare Industry
CategoryHealth products - Drugs
CompaniesTeva Canada Limited. 30 Novopharm Court Toronto, ON M1B 2K9
Published byHealth Canada
Recall classType II
Alert / recall typeHealth product recall
Identification numberRA-76728
Background{}
CompaniesTeva Canada Limited. 30 Novopharm Court Toronto, ON M1B 2K9
AudiencesGeneral public Healthcare Industry
Source updated2024-12-20

Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.

Official source Monitor products Back to recalls

Starting...

Related recalls

Similar recalls and safety notices.

Loading related recalls...